Divamics home

Hit-to-lead, lead-to-PCC optimization

Target identification

Breaking Boundaries in Pharmaceutical

Innovation

Customized

Solutions

Biotrajectory search

Simulation

online

Dynamics-based Drug Discovery

Flexible, demand-driven resources to optimize the value of your research investment

Proposing a molecular design paradigm and overcoming the challenges of new drug design for undruggable targets

Drug Discovery Solution Provider based on Molecular Dynamics Simulation

Applying our comprehensive understanding of protein structure and flexibility to drug discovery in a dynamic environment

Full process

DIVAMICS provides full process services in multiple areas

MD only problem

Small molecule drug discovery

Peptide & XDC

PROTAC

Synthetic biology

Animal health

DIVAMICS is an interdisciplinary biopharmaceutical company driven by cutting-edge technologies such as artificial intelligence, quantum mechanics, and molecular simulation algorithms .

Target modeling and mechanism elucidation

Hit screening

Wide range

Concentrate, focus, professional

DIVAMICS's value and

professional scientific team

Dr. Hao Liu, CSO

CSO

List price:0.00

Price:0.00

· Ph. D. in Chemistry, University of Florida· Used to be data engineer in Genentech· Leadi
Jinbo Yang, M.A.

CFO

List price:0.00

Price:0.00

• Responsible for the company's operation and internal control• Master of National Economy,
Xinyi Shen, M.S.

Director of Strategy and Business Development

List price:0.00

Price:0.00

• Responsible for marketing, business, public relationship• Received a Master's degree in D
Jiang Chang

Medicinal Chemistry

List price:0.00

Price:0.00

Total 4 record(s)1

DICAMICS's value

Dr. John Zheng

CEO

" DIVAMICS was awarded Suzhou Industrial Park Science and Technology Leadership Project at the beginning of its establishment, and was approved for the Suzhou Gusu Leadership Talent Project in 2022. One of the company’s core algorithms, the MovableType free energy algorithm, has been acknowledged and recommended by Roald Hoffman, the 1981 Nobel Prize winner in Chemistry.

DIVAMICS have a wide range of cooperation including ...

News

Free Energy Calculations Using the Movable Type Method with Molecular Dynamics Driven Protein−Ligand Sampling

This cover article for the October 2022 issue of the Journal of Chemical Information and Modeling (JCIM) provides an in-depth look at the results of a three-way collaboration between Divamics' technical team, Wuhan University of Technology, And QuantumBio Inc., an US computer-based drug design software company. The paper was co-authored by Wenlang Liu, Zhenhao Liu, Hao Liu, Lance M. Westerhoff and Zheng Zheng.

View details ➜
The Conformational Transition Pathways and Hidden Intermediates in DFG-Flip Process of c‑Met Kinase Revealed by Metadynamics Simulations

The cover article of JCIM in the July 2022 issue showed the results of a collaborative project between Divamics, Wuhan University of Technology, and Institute of Precision Measurement, Chinese Academy of Sciences. In this work, the meta-dynamics approach was used to analyze the flexibility mechanism of c-Met target proteins, which play important roles in RAS, PI3K, STAT and other pathways.

View details ➜

Total 2 record(s)1

Academic achievements

DIVAMICS Latest

news and academic achievements

DBDD reveals membrane protein dynamics: a molecular movie of GPCR

2024-06-03
LIDE and Divamics have entered into a strategic partnership to accelerate the integration of “BT + IT” and empower new drug development

2024-06-03
AI+molecular dynamics new drug discovery company DIVAMICS completed the second round of financing, led by Fosun Pharmaceuticals Rehabilitation Suzhou Angel Fund

DIVAMICS is a new drug molecule discovery factory based on DBDD（Dynamics-based Drug Discovery, focusing on early drug research and development, providing CRO services for new drug discovery for innovative drug enterprises. At the beginning of its establishment, the company was rated as a leading technology project enterprise in Suzhou Industrial Park.

2023-05-08

Total 6 record(s)12 Next> Last

AI+molecular dynamics new drug discovery company DIVAMICS completed the second round of financing, led by Fosun Pharmaceuticals Rehabilitation Suzhou Angel Fund

2023-05-08

DIVAMICS is a new drug molecule discovery factory based on DBDD（Dynamics-based Drug Discovery, focusing on early drug research and development, providing CRO services for new drug discovery for innovative drug enterprises. At the beginning of its establishment, the company was rated as a leading technology project enterprise in Suzhou Industrial Park. 【detailed】
The Conformational Transition Pathways and Hidden Intermediates in DFG-Flip Process of c‑Met Kinase Revealed by Metadynamics Simulations

2023-08-29

The cover article of JCIM in the July 2022 issue showed the results of a collaborative project between Divamics, Wuhan University of Technology, and Institute of Precision Measurement, Chinese Academy of Sciences. In this work, the meta-dynamics approach was used to analyze the flexibility mechanism of c-Met target proteins, which play important roles in RAS, PI3K, STAT and other pathways.【detailed】
MD-only problem

2024-06-03

GPCR drug design
Allosteric site drug design
PPI drug design【detailed】
Free Energy Calculations Using the Movable Type Method with Molecular Dynamics Driven Protein−Ligand Sampling

2023-08-29

This cover article for the October 2022 issue of the Journal of Chemical Information and Modeling (JCIM) provides an in-depth look at the results of a three-way collaboration between Divamics' technical team, Wuhan University of Technology, And QuantumBio Inc., an US computer-based drug design software company. The paper was co-authored by Wenlang Liu, Zhenhao Liu, Hao Liu, Lance M. Westerhoff and Zheng Zheng.【detailed】
DBDD reveals membrane protein dynamics: a molecular movie of GPCR

2024-06-03

【detailed】
The Conformational Transition Pathways and Hidden Intermediates in DFG-Flip Process of c‑Met Kinase Revealed by Metadynamics Simulations

2023-08-29

The cover article of JCIM in the July 2022 issue showed the results of a collaborative project between Divamics, Wuhan University of Technology, and Institute of Precision Measurement, Chinese Academy of Sciences. In this work, the meta-dynamics approach was used to analyze the flexibility mechanism of c-Met target proteins, which play important roles in RAS, PI3K, STAT and other pathways.【detailed】
Free Energy Calculations Using the Movable Type Method with Molecular Dynamics Driven Protein−Ligand Sampling

2023-08-29

This cover article for the October 2022 issue of the Journal of Chemical Information and Modeling (JCIM) provides an in-depth look at the results of a three-way collaboration between Divamics' technical team, Wuhan University of Technology, And QuantumBio Inc., an US computer-based drug design software company. The paper was co-authored by Wenlang Liu, Zhenhao Liu, Hao Liu, Lance M. Westerhoff and Zheng Zheng.【detailed】
LIDE and Divamics have entered into a strategic partnership to accelerate the integration of “BT + IT” and empower new drug development

2024-06-03

【detailed】
Dr. Liu Hao, CSO, has been selected for the list of X.36under36S level entrepreneurs on the 36Kr platform

2023-09-18

【detailed】